Discontinued — last reported Q3 '24
Consumer Tissue Products — Operating Profit
Kimberly-Clark Consumer Tissue Products — Operating Profit increased by 8.2% to $265.00M in Q3 2024 compared to the prior quarter. Year-over-year, this metric declined by 0.7%, from $267.00M to $265.00M. Over 2 years (FY 2021 to FY 2023), Consumer Tissue Products — Operating Profit shows relatively stable performance with a 4.8% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
Higher operating profit indicates effective cost management and strong pricing power relative to input costs like pulp and energy.
Detailed definition
This metric represents the total operating income generated by the consumer tissue segment after accounting for cost of...
Peer comparison
Operating margins in this segment are often compared against other global household product manufacturers to gauge relative efficiency.
kmb_segment_consumer_tissue_products_operating_profitHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $196.00M | $222.00M | $201.00M | $171.00M | $178.00M | $218.00M | $239.00M | $240.00M | $200.00M | $267.00M | $269.00M | $290.00M | $245.00M | $265.00M |
| QoQ Change | — | +13.3% | -9.5% | -14.9% | +4.1% | +22.5% | +9.6% | +0.4% | -16.7% | +33.5% | +0.7% | +7.8% | -15.5% | +8.2% |
| YoY Change | — | — | — | — | -9.2% | -1.8% | +18.9% | +40.4% | +12.4% | +22.5% | +12.6% | +20.8% | +22.5% | -0.7% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Kimberly-Clark's consumer tissue products — operating profit?
- Kimberly-Clark (KMB) reported consumer tissue products — operating profit of $265.00M in Q3 2024.
- How has Kimberly-Clark's consumer tissue products — operating profit changed year-over-year?
- Kimberly-Clark's consumer tissue products — operating profit decreased by 0.7% year-over-year, from $267.00M to $265.00M.
- What is the long-term trend for Kimberly-Clark's consumer tissue products — operating profit?
- Over 2 years (2021 to 2023), Kimberly-Clark's consumer tissue products — operating profit has grown at a 4.8% compound annual growth rate (CAGR), from $888.00M to $976.00M.
- What does consumer tissue products — operating profit mean?
- The total profit earned by the consumer tissue segment from its core business operations.